International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-6 doi: 10.5281/zenodo.10474750
Original Article
Comparison of C-Reactive Protein Levels in Preeclampsia Pregnant Women with Normal Trimester III Pregnant Women
 ,
 ,
 ,
Published
Dec. 31, 2023
Abstract

Background:The increase in maternal mortality rates (MMR) is an occurrence that needs attention in Indonesia. According to Dinas Kesehatan Jawa Timur, 2019 the MMR in 2020 reached 98,39 per 100.000 live births, with approximately 26,9% or 152 individuals attributed to hypertension during pregnancy. Hypertension is diagnosed with systolic blood pressure reaches more than 140 mmHg and diastolic blood pressure is 90 mmHg. This condition becomes more concerning if hypertension develops after 20 weeks of pregnancy and is accompanied by proteinuria or other organ damage, known as preeclampsia. One of the strongest theory is the presence of uteroplacental ischemia and maternal infection, leading to an increase in pro-inflammatory cytokines (TNF-alpha and IL-6). Thus, it can be concluded that there is an increase in the inflammatory response at low levels. The presence of IL-6 induced the formation of C-Reactive Protein (CRP), a primary biomarker for inflammation if its value is > 0.3 mg/dl, requiring specific attention and appropriate management.

Methods: This study aims to determine the comparison of CRP levels in preeclamptic pregnant women with normal third-trimester pregnant women at Bhakti Dharma Husada Hospital in 2023. The research took place from October 2023 to November 2023. Patient characteristics were obtained through secondary data from patient medical records, and CRP data were obtained from laboratory test.

Results:The research, involving 20 pregnant women, found a significant difference using non-parametric Mann-Whitney test between the preeclampsia group and the normal third-trimester pregnant group (P<0,05).

Conclusions:This indicates that the occurrence of preeclampsia has an impact on increasing CRP.

Recommended Articles
Loading Image...
Volume-4, Issue-6
Citations
2533 Views
413 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved